All Stories

  1. Evaluating methods to quantify the effect of deprescribing a medication on patient clinical outcomes using a simulation study
  2. Prescription Intervals of Medications for Chronic Use: A Cohort Study
  3. Prevalence of drug-drug interactions (DDIs) involving clozapine: a systematic review
  4. Practice‐level variation in potentially inappropriate prescribing in middle‐aged adults: A repeated cross‐sectional study in South London general practice
  5. Frequency and Timing of Specialized Formula Prescriptions for Children Under 2 Years
  6. Association between ADHD and multimorbidity in adulthood: a systematic review protocol
  7. Evaluating the impact of a policy restricting reimbursement of lidocaine plaster prescribing on opioid and other analgesic prescribing
  8. Fall-risk-increasing drug use in older community-dwelling adults: prevalence, association with fall-related admissions and post-discharge prescribing changes—a retrospective cohort study
  9. Identification of Potentially Inappropriate Medications for Adults Below 65 Years: Protocol for a Modified Delphi Study
  10. Reporting patterns of adverse drug withdrawal events using individual case safety reports in United States and European databases
  11. Prescription intervals of medications for chronic use: a cohort study
  12. Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing
  13. Medical Device Industry Payments to Healthcare Professionals and Organizations in Japan: An Evaluation of Scale, Distribution, and Transparency Practices, 2019-2022
  14. Avoiding being the “busy fool”: How general practitioners perceive and engage with a prescribing safety and quality dashboard
  15. An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts
  16. Trends in the Chronic Use and Discontinuation of Potentially Inappropriate Medications in Older Adults
  17. Characterising prescribing cascades in older community-dwelling adults attending general practice in The Netherlands: a retrospective cohort study
  18. An essential medicines list in Ireland: A qualitative interview study of interest-holders
  19. Adverse Drug Reaction-Related Hospital Admissions and Adverse Drug Events and Their Association with Short- and Long-Term Health Outcomes in Older Adults
  20. A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety
  21. Identifying core teamwork competencies for community-based health and social care professionals: an e-Delphi study
  22. Analysing the impact of complex multimorbidity on health-related quality of life
  23. Prevalence and impact of prescribing cascades in community‐dwelling adults: Longitudinal analysis of the Irish longitudinal study on ageing (TILDA)
  24. The association between STOPPFall medication use and orthostatic hypotension in community-dwelling older people
  25. Identifying outcomes for evaluating the impact of pharmacist prescribing: A rapid overview of reviews.
  26. Changes in benzodiazepine, z-drug, and other sedative prescribing in primary care in Ireland between 2014 and 2022
  27. Potentially inappropriate prescribing and falls-risk increasing drugs in people who have experienced a fall: a systematic review and meta-analysis
  28. An essential medicines list in Ireland: A qualitative interview study of interest-holders
  29. Pharmaceutical company promotional payments to English general practices: longitudinal study
  30. Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022: A repeated cross‐sectional study
  31. Identifying predictors of medication-related harm in older populations: a latent class analysis approach
  32. Medicines support and socIal prescribing to aDdress pAtient prioritieS in multimorbidity (MIDAS): A process evaluation protocol
  33. The healthcare costs of poor air quality in Ireland: A review of potential data sources and methods
  34. Developing and assessing the usability of a prescribing quality and safety dashboard in Irish general practice: protocol for a qualitative study
  35. Effectiveness of interactive dashboards to optimize prescribing in general practice: a systematic review
  36. Impact of eliciting treatment priorities on analgesic prescribing in older patients with high levels of polypharmacy
  37. Medicines support and social prescribing to address patient priorities in multimorbidity (MIDAS): protocol for a definitive, multi-arm, cluster randomised, controlled trial in Irish general practice
  38. RxTrends: An R-based Shiny Application for Visualising Open Data on Prescribed Medications in Ireland
  39. Added Therapeutic Benefits of Top‐Selling Drugs in Japan: A Cross‐Sectional Study Using Health Technology Assessment
  40. Pharmacoepidemiology simulation study practices: A methodological review
  41. The association between STOPPFall medication use and falls and fractures in community-dwelling older people
  42. Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch study
  43. Prevalence of potentially inappropriate prescribing in community-dwelling older adults: an application of STOPP/START version 3 to The Irish Longitudinal Study on Ageing (TILDA)
  44. Potentially inappropriate prescribing and falls-risk increasing drugs in people who have experienced a fall; a systematic review and meta-analysis
  45. Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: Findings from the Irish longitudinal study on ageing (TILDA) in 2016
  46. RxTrends: An R-based Shiny Application for Visualising Open Data on Prescribed Medications in Ireland
  47. Use of complementary and alternative medicine (CAM) among people living with Sjögren’s: a cross-sectional survey using a modified international CAM questionnaire (I-CAM-Q)
  48. Effectiveness of interactive dashboards to optimise prescribing in primary care: a protocol for a systematic review
  49. Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures
  50. Associations between pharmaceutical industry interactions and prescribing practices in chronic non-malignant pain management: A protocol for a systematic review
  51. Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults
  52. Adverse drug reactions and events in an Ageing PopulaTion risk Prediction (ADAPTiP) tool: the development and validation of a model for predicting adverse drug reactions and events in older patients
  53. Prevalence and predictors of sub-optimal laboratory monitoring of selected higher risk medicines in Irish general practice: a 5-year retrospective cohort study of community-dwelling older adults
  54. Development and Implementation of Deprescribing Guidelines
  55. Optimising Medication Therapy in Older People
  56. Core medication use in general practice prescriptions: A pilot study evaluating the Drug Utilization 90% Index in Irish general practice
  57. Trends and patterns of sedative prescribing in primary care in Ireland between 2014 and 2022 - a repeated cross-sectional study
  58. Potentially inappropriate prescribing in middle-aged adults: a significant problem with a lack of action and evidence to address it
  59. The Association Between Psychotropic Medication Use and Gait and Mobility Impairment in Community-Dwelling Older People: Data From The Irish Longitudinal Study on Ageing (TILDA)
  60. Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology–endorsed systematic review of methodology
  61. Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysis
  62. Patterns of pain medication usage and self-reported pain in older Irish adults with osteoarthritis: A latent class analysis of data from the Irish Longitudinal Study on Ageing
  63. Time Trends, Regional Variation and Associations of Low‐Allergy Formula Prescribing in England
  64. Medication adherence for people with acquired communication disorders: A systematic review
  65. Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities
  66. Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial
  67. Effectiveness of interactive dashboards to optimise prescribing in general practice: A systematic review
  68. Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: findings from The Irish Longitudinal Study on Ageing (TILDA) in 2016
  69. The Development of Principles for Patient and Public Involvement (PPI) in Preclinical Spinal Cord Research: A Modified Delphi Study
  70. Effectiveness of interactive dashboards to optimise prescribing in primary care: a protocol for a systematic review
  71. Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals
  72. Prevalence and risk factors for milk allergy overdiagnosis in the BEEP trial cohort
  73. Evaluating time to withdrawal of anti-cancer drug indications that received FDA’s accelerated approval
  74. Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022 - a repeated cross-sectional study
  75. Stakeholder perceptions of and attitudes towards problematic polypharmacy and prescribing cascades: a qualitative study
  76. Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: An observational study
  77. Adverse Drug reactions in an Ageing PopulaTion risk Prediction (ADAPTiP) tool: the development of a model for predicting adverse drug reaction-related hospital admissions in older patients
  78. What do clinical practice guidelines say about deprescribing? A scoping review
  79. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
  80. Measuring Quality of Life in Deprescribing Trials: A Scoping Review
  81. Epidemiology and management of oral cavity squamous cell carcinoma in Ireland
  82. The role of Patient and public involvement (PPI) in pre-clinical spinal cord research: An interview study
  83. Primary care prescribing prior to lung cancer diagnosis (PPP-Lung): protocol for a systematic review
  84. Pediatric blood cultures—turning up the volume: a before and after intervention study
  85. Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis
  86. Paediatric Escherichia coli urinary tract infection: susceptibility trends and clinical management—a retrospective analysis of a 10-year period
  87. Challenges in identifying and quantifying country-level participation in multi-country randomised controlled trials involving Ireland as a collaborating partner
  88. Perspectives of researchers and clinicians on patient and public involvement (PPI) in preclinical spinal cord research: An interview study
  89. Potentially Inappropriate Prescribing and Potential Prescribing Omissions and Their Association with Adverse Drug Reaction-Related Hospital Admissions
  90. Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population
  91. Trends in medication use at the onset of and during the COVID‐19 pandemic in the Republic of Ireland: An interrupted time series study
  92. Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study
  93. Medication Adherence for People with Acquired Communication Disorders: A Systematic Review
  94. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2016-2021: A methodological report
  95. Effect of COVID-19 vaccines for the treatment of people with post-COVID-19 condition: a rapid review
  96. Perspectives of Researchers and Clinicians on Patient and Public Involvement (PPI) in Preclinical Spinal Cord Research: An Interview Study
  97. The role of Patient and Public Involvement (PPI) in pre-clinical spinal cord research: an interview study
  98. Potentially inappropriate prescribing in middle-aged adults: A significant problem with a lack of action and evidence to address it.
  99. Survival in an era of organ preservation: an update on laryngeal cancer in Ireland
  100. Trends in medication use after the onset of the COVID-19 pandemic in the Republic of Ireland: an interrupted time series study
  101. Use of pharmacy services in community-dwelling middle-aged and older adults; findings from The Irish Longitudinal Study on Ageing (TILDA)
  102. The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe
  103. Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studies
  104. Clinical study reports published by the European Medicines Agency 2016–2018: a cross-sectional analysis
  105. A blended model to support brief interventions in primary care: A qualitative study of usability and acceptability of HealthEir in community pharmacy
  106. Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: an observational study
  107. The association between weather warnings and hip fractures in the Republic of Ireland
  108. Recruiting general practitioners and older patients with multimorbidity to randomized trials
  109. Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study
  110. Association between patient attitudes towards deprescribing and subsequent prescription changes
  111. Use of pharmacy services in community-dwelling middle-aged and older adults; findings from The Irish Longitudinal Study on Ageing (TILDA)
  112. Formal health care costs among older people in Ireland: methods and estimates using The Irish Longitudinal Study on Ageing (TILDA)
  113. The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe
  114. Value assessment of deprescribing interventions: Suggestions for improvement
  115. Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studies
  116. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review
  117. Association between patient attitudes towards deprescribing and subsequent prescription changes
  118. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: A systematic review
  119. Is There Evidence of an Association Between Acute Health Care Utilization and Function in Older Adults Over Time? A Population-Based Cohort Study
  120. Key items for reports of primary care research: an international Delphi study
  121. Medication safety incidents associated with the remote delivery of primary care: a rapid review
  122. Overprescribing among older people near end of life in Ireland: Evidence of prevalence and determinants from The Irish Longitudinal Study on Ageing (TILDA)
  123. Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy
  124. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study
  125. Effect of COVID-19 vaccines for the treatment of people with post-COVID-19 condition: a rapid review
  126. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2017-2021: A methodological report
  127. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial
  128. Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals’ knowledge and views, and ethical and legal concerns
  129. Prescribing cascades in community‐dwelling adults: A systematic review
  130. Evaluation of policies and practices to support safe and appropriate analgesic and sedative prescribing: The CDRx (controlled drug prescribing) protocol
  131. What is the impact of multimorbidity on out-of-pocket healthcare expenditure among community-dwelling older adults in Ireland? A cross-sectional study
  132. Medication changes  and potentially inappropriate prescribing in older patients with significant  polypharmacy: a secondary analysis of the SPPiRE trial            
  133. Prescribing cascades in community-dwelling adults: a systematic review
  134. Prescribing trends in older patients with multimorbidity and significant polypharmacy recruited to the SPPiRE trial
  135. Development of the ADFICE_IT Models for Predicting Falls and Recurrent Falls in Community-Dwelling Older Adults: Pooled Analyses of European Cohorts With Special Attention to Medication
  136. Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care
  137. Cost outcomes of potentially inappropriate prescribing in middle‐aged adults: A Delphi consensus and cross‐sectional study
  138. Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data
  139. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial
  140. A systematic review of the prevalence, determinants, and impact of potentially inappropriate prescribing in middle-aged adults
  141. ‘More of an art than a science’? The development, design and mechanics of the Delphi Technique
  142. Opioid and analgesic utilization in Ireland in 2000 and 2015: A repeated cross‐sectional study
  143. Prescribing cascades in community-dwelling adults: protocol for a systematic review
  144. Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis
  145. GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study
  146. Prescribing cascades in community-dwelling adults: protocol for a systematic review
  147. Age alone is not a barrier to concurrent chemoradiotherapy for advanced head and neck cancer
  148. Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
  149. Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reports
  150. Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis
  151. How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England
  152. Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study
  153. Cognitive decline associated with anticholinergics, benzodiazepines and Z‐drugs: Findings from The Irish Longitudinal Study on Ageing (TILDA)
  154. Factors associated with initiation of bone-health medication among older adults in primary care in Ireland
  155. Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
  156. Aspirin prescribing in cardiovascular disease in middle-aged and older adults in Ireland: findings from The Irish Longitudinal Study on Ageing
  157. Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care
  158. How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England.
  159. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study
  160. Cognitive decline associated with anticholinergics, benzodiazepines, and Z-drugs: findings from The Irish Longitudinal Study on Ageing (TILDA)
  161. Pharmacists in general practice: a qualitative process evaluation of the General Practice Pharmacist (GPP) study
  162. The Development of an Accreditation Framework for Continuing Education Activities for Pharmacists
  163. High-risk categories for COVID-19 and their distribution by county in Republic of Ireland-evidence from the TILDA study
  164. TILDA report to inform demographics for over 50s in Ireland for COVID-19 crisis
  165. Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reports
  166. A comparison of contemporary versus older studies of aspirin for primary prevention
  167. Comparing Potentially Inappropriate Prescribing Tools and Their Association With Patient Outcomes
  168. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non‐randomised pilot study
  169. Potentially serious alcohol–medication interactions and falls in community-dwelling older adults: a prospective cohort study
  170. Association of Antidepressants With Recurrent, Injurious and Unexplained Falls is Not Explained by Reduced Gait Speed
  171. A comparison of contemporary versus older studies of aspirin for primary prevention
  172. Modification of Potentially Inappropriate Prescribing Following Fall-Related Hospitalizations in Older Adults
  173. Prescriber Variation in Relation to Prescribing Trends within the Preferred Drugs Initiative in Ireland (2012–2015): An Interrupted Time-Series Study Using Latent Curve Models
  174. Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models
  175. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study
  176. Self-report versus electronic medical record recorded healthcare utilisation in older community-dwelling adults: Comparison of two prospective cohort studies
  177. Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron
  178. The PIPc Study—application of indicators of potentially inappropriate prescribing in children (PIPc) to a national prescribing database in Ireland: a cross-sectional prevalence study
  179. Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron
  180. Deprescribing guidelines: An international symposium on development, implementation, research and health professional education
  181. Deprescribing recommendations: An essential consideration for clinical guideline developers
  182. Deprescribing: Future directions for research
  183. Fixed-dose combination antihypertensives and risk of medication errors
  184. Supporting prescribing in Irish primary care: protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care
  185. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011–2016): an interrupted time-series study
  186. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms
  187. Potentially inappropriate prescribing and its association with health outcomes in middle-aged people: a prospective cohort study in Ireland
  188. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot
  189. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012
  190. PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique
  191. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study
  192. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria
  193. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study
  194. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people
  195. Potentially Inappropriate Medicines and Potential Prescribing Omissions in Older People and Their Association With Health Care Utilization: A Retrospective Cohort Study
  196. Potentially Inappropriate Prescribing and Vulnerability and Hospitalization in Older Community-Dwelling Patients
  197. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA)
  198. Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older People